SARS_CoV 2 Clinical Trials in Cincinnati
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
J
Active, not recruiting
- SARS-CoV 2
- SARS-CoV-2 convalescent plasma
- Plasma from a volunteer donor
- Birmingham, Alabama
- +24 more
2021-11-15
Nov 15, 2021N
Terminated
- COVID-19
- SARS-CoV 2
- Hydroxychloroquine (HCQ)
- +3 more
- Birmingham, Alabama
- +10 more
2021-11-12
Nov 12, 2021K
Recruiting
- COVID 19
- +2 more
- Mavrilimumab
- Placebo
- Cincinnati, OhioUniversity of Cincinnati
2020-07-28
Jul 28, 2020